Jounce Therapeutics, Inc. Gross Margin 2017-2022 | JNCE
Current and historical gross margin for Jounce Therapeutics, Inc. (JNCE) over the last 10 years. The current gross profit margin for Jounce Therapeutics, Inc. as of December 31, 2022 is %.
Gross Margin Historical Data |
Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
2021-12-31 |
$0.03B |
$0.03B |
100.00% |
2019-12-31 |
$0.15B |
$0.15B |
100.00% |
2019-09-30 |
$0.17B |
$0.17B |
100.00% |
2019-06-30 |
$0.06B |
$0.06B |
100.00% |
2019-03-31 |
$0.07B |
$0.07B |
100.00% |
2018-12-31 |
$0.07B |
$0.07B |
100.00% |
2018-09-30 |
$0.06B |
$0.06B |
100.00% |
2018-06-30 |
$0.06B |
$0.06B |
100.00% |
2018-03-31 |
$0.06B |
$0.06B |
100.00% |
2017-12-31 |
$0.07B |
$0.07B |
100.00% |
2017-09-30 |
$0.08B |
$0.08B |
100.00% |
2017-06-30 |
$0.08B |
$0.08B |
100.00% |